Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Jiangsu Zhenjiang New Energy Equipment (603507.SH) plans to sell 100% equity of its American subsidiary Zhenjiang for a transaction price of 22.15 million US dollars.

US Stock Market Move | Nasdaq Golden Dragon Index drops by 1.53%, popular Chinese concept stocks generally declined.

Richmond Fed President: The impact of the Middle East conflict on monetary policy depends on its duration. Energy price fluctuations are one of the important factors.
Jiangsu Zhenjiang New Energy Equipment (603507.SH) plans to sell 100% equity of its American subsidiary Zhenjiang for a transaction price of 22.15 million US dollars.

US Stock Market Move | Nasdaq Golden Dragon Index drops by 1.53%, popular Chinese concept stocks generally declined.

Richmond Fed President: The impact of the Middle East conflict on monetary policy depends on its duration. Energy price fluctuations are one of the important factors.

RECOMMEND





